 the patient. CAS should
be reserved for symptomatic patients with stenosis of 50% to 99% at high risk for CEA for anatomic or medical reasons.
CAS is not recommended for asymptomatic patients at this time. Asymptomatic patients at high risk for intervention or
with <3 years life expectancy should be considered for medical management as the first-line therapy. ( J Vasc Surg 2011;
54:e1-e31.)

